BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16447656)

  • 1. [Stem cells transplantation for ischemic heart disease].
    Huang RC; Ge JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):772-7. PubMed ID: 16447656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-coronary transplantation may be an optimal route in cellular cardiomyoplasty with stem cells.
    Li ZZ; Bai SG; Huang J; Qian HY
    Med Hypotheses; 2007; 69(6):1212-8. PubMed ID: 17555882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stem cell therapy in ischemic heart disease].
    Diederichsen AC; Møller JE; Kristiansen MA; Saekmose SG; Barington T; Videbaek LM; Kassem MS; Thayssen P
    Ugeskr Laeger; 2006 Mar; 168(11):1111-4. PubMed ID: 16545213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations.
    Perin EC; Silva GV
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):281-8. PubMed ID: 19213080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell therapy for ischemic heart disease: where are we?
    LaPar DJ; Kron IL; Yang Z
    Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of progenitor cells in ischemic heart disease--Past, present and future.
    Hristov M; Weber C
    Basic Res Cardiol; 2006 Jan; 101(1):1-7. PubMed ID: 16382288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair.
    Pesce M; Burba I; Gambini E; Prandi F; Pompilio G; Capogrossi MC
    Pharmacol Ther; 2011 Jan; 129(1):50-61. PubMed ID: 21035506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of traditional Chinese medicine for stem cell therapy of ischemic heart disease].
    Wu H; Hu Y; Zhou Y; Chu Y
    Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):935-8. PubMed ID: 19639769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of stem cells in elderly patients with cardiovascular disease.
    Brehm M; Stanske B; Strauer BE
    Exp Gerontol; 2008 Nov; 43(11):1024-32. PubMed ID: 18845234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic tissue repair by autologous bone marrow-derived stem cells: scientific basis and preclinical data.
    Quraishi A; Losordo DW
    Handb Exp Pharmacol; 2007; (180):167-79. PubMed ID: 17554508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stem cells after myocardial infarction].
    Schächinger V; Dimmeler S; Zeiher AM
    Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapy for chronic ischemic heart disease--a clinical perspective.
    Perin EC; Silva GV
    Cardiovasc Ther; 2011 Jun; 29(3):211-7. PubMed ID: 20955540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential.
    Raman SV; Cooke GE; Binkley PF
    Circulation; 2003 May; 107(20):e195; author reply e195. PubMed ID: 12777326
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue.
    Zhu XY; Zhang XZ; Xu L; Zhong XY; Ding Q; Chen YX
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1084-90. PubMed ID: 19146824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome.
    Ben-Dor I; Fuchs S; Kornowski R
    J Am Coll Cardiol; 2006 Oct; 48(8):1519-26. PubMed ID: 17045883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis with bone marrow--derived stem cells.
    Tse HF; Lau CP
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):89-97. PubMed ID: 17562779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration.
    Tateishi K; Ashihara E; Takehara N; Nomura T; Honsho S; Nakagami T; Morikawa S; Takahashi T; Ueyama T; Matsubara H; Oh H
    J Cell Sci; 2007 May; 120(Pt 10):1791-800. PubMed ID: 17502484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia.
    Ziebart T; Yoon CH; Trepels T; Wietelmann A; Braun T; Kiessling F; Stein S; Grez M; Ihling C; Muhly-Reinholz M; Carmona G; Urbich C; Zeiher AM; Dimmeler S
    Circ Res; 2008 Nov; 103(11):1327-34. PubMed ID: 18927463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-based stem cell and gene therapy for refractory myocardial ischemia.
    Fuchs S; Battler A; Kornowski R
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S89-95. PubMed ID: 17230221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.